Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation: Pidotimod in SARS-CoV-2 vaccination. Mediterr J Hematol Infect Dis [Internet]. 2022 Feb. 27 [cited 2026 May 26];14(1):e2022023. Available from: https://www.mjhid.org/mjhid/article/view/4820